ROIV
Roivant Sciences Ltd. · Healthcare
Director Keith S Manchester sold $56.4M of Roivant Sciences Ltd.
Sold$56,444,076
$34.46Price
1,638,163Shares
−48%Stake
What ROIV did after the filing
- The stock from Wed, Jul 1 open, $35.75
- +1.5%
- S&P 500, same days
- +4.4%
Measured over 30 trading days, to the Aug 13 close.
Traded Fri, Jun 26. Filed Tue, Jun 30, 8:38 PM ET, after the close. Returns use the Jul 1 open and the Aug 13 close. Not investment advice.